title: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.
authors: Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Commercial Road, Melbourne 3004, Australia. i.glaspole@alfred.org.au.
authors: Ian N
authors: IN
authors: Glaspole
authors: Ryan F
authors: RF
authors: Hoy
authors: Peter F
authors: PF
authors: Ryan
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068582:Certolizumab Pegol; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D011092:Polyethylene Glycols / Q000009:adverse effects*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007140:Immunoglobulin Fab Fragments; D007166:Immunosuppressive Agents; D011092:Polyethylene Glycols; D000068582:Certolizumab Pegol